Role of MicroRNAs in NAFLD/NASH

被引:74
作者
Szabo, Gyongyi [1 ]
Csak, Timea [1 ,2 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Med, LRB215,364 Plantat St, Worcester, MA 01605 USA
[2] Brookdale Univ Hosp & Med Ctr, 1 Brookdale Plaza, Brooklyn, NY 11212 USA
关键词
MicroRNAs; NASH; NAFLD; FATTY LIVER-DISEASE; OBSTRUCTIVE SLEEP-APNEA; NONALCOHOLIC STEATOHEPATITIS; ADIPOSE-TISSUE; CIRCULATING MICRORNAS; METABOLIC SYNDROME; URIC-ACID; GUT MICROBIOTA; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION;
D O I
10.1007/s10620-015-4002-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
MicroRNAs (miRNAs) are highly conserved, small, 18-25 nucleotide, non-coding RNAs that regulate gene expression at the post-transcriptional level. Each miRNA can regulate hundreds of target genes, and vice versa each target gene can be regulated by numerous miRNAs, suggesting a very complex network and explaining how miRNAs play pivotal roles in fine-tuning essentially all biological processes in all cell types in the liver. Here, we summarize the current knowledge on the role of miRNAs in the pathogenesis and diagnosis of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) with an outlook to the broader aspects of metabolic syndrome. Furthermore, we discuss the role of miRNAs as potential biomarkers and therapeutic targets in NAFLD/NASH.
引用
收藏
页码:1314 / 1324
页数:11
相关论文
共 141 条
[1]   MicroRNAs in obesity-associated disorders [J].
Abente, Eugenio J. ;
Subramanian, Murugan ;
Ramachandran, Vimal ;
Najafi-Shoushtari, S. Hani .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2016, 589 :108-119
[2]   Obstructive sleep apnea syndrome and fatty liver: Association or causal link? [J].
Ahmed, Mohamed H. ;
Byrne, Christopher D. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (34) :4243-4252
[3]   Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet [J].
Ahn, Jiyun ;
Lee, Hyunjung ;
Jung, Chang Hwa ;
Ha, Taeyoul .
MOLECULAR NUTRITION & FOOD RESEARCH, 2012, 56 (11) :1665-1674
[4]   miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity [J].
Allen, Ryan M. ;
Marquart, Tyler J. ;
Albert, Carolyn J. ;
Suchy, Frederick J. ;
Wang, David Q. -H. ;
Ananthanarayanan, Meenakshisundaram ;
Ford, David A. ;
Baldan, Angel .
EMBO MOLECULAR MEDICINE, 2012, 4 (09) :882-895
[5]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[6]   Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease [J].
Aqel, Bashar ;
DiBaise, John K. .
NUTRITION IN CLINICAL PRACTICE, 2015, 30 (06) :780-786
[7]   Adipose Tissue MicroRNAs as Regulators of CCL2 Production in Human Obesity [J].
Arner, Erik ;
Mejhert, Niklas ;
Kulyte, Agne ;
Balwierz, Piotr J. ;
Pachkov, Mikhail ;
Cormont, Mireille ;
Lorente-Cebrian, Silvia ;
Ehrlund, Anna ;
Laurencikiene, Jurga ;
Heden, Per ;
Dahlman-Wright, Karin ;
Tanti, Jean-Francois ;
Hayashizaki, Yoshihide ;
Ryden, Mikael ;
Dahlman, Ingrid ;
van Nimwegen, Erik ;
Daub, Carsten O. ;
Arner, Peter .
DIABETES, 2012, 61 (08) :1986-1993
[8]   MicroRNA regulatory networks in human adipose tissue and obesity [J].
Arner, Peter ;
Kulyte, Agne .
NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (05) :276-288
[9]   Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma [J].
Arroyo, Jason D. ;
Chevillet, John R. ;
Kroh, Evan M. ;
Ruf, Ingrid K. ;
Pritchard, Colin C. ;
Gibson, Donald F. ;
Mitchell, Patrick S. ;
Bennett, Christopher F. ;
Pogosova-Agadjanyan, Era L. ;
Stirewalt, Derek L. ;
Tait, Jonathan F. ;
Tewari, Muneesh .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) :5003-5008
[10]   Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace [J].
Baffy, Gyoergy ;
Brunt, Elizabeth M. ;
Caldwell, Stephen H. .
JOURNAL OF HEPATOLOGY, 2012, 56 (06) :1384-1391